Concurrent radiation and intracarotid cisplatin infusion in malignant gliomas

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 20, Issue 2, 1997, Pages 138-142

  Fountzilas, George ^a   Karavelis, Antonios ^a   Makrantonakis, Paris ^a   Selviaridis, Panayiotis ^a   Tzitzikas, John ^a   Kalogera Fountzila, Anna ^a   Hatzibaloglou, Ananias ^a   Karkavelas, George ^a   Foroglou, George ^a   Tourkantonis, Achilles ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cisplatin; Intracarotid chemotherapy; Malignant gliomas; Radiation; Toxicities

Indexed keywords

CARBOPLATIN; CISPLATIN; COBALT 60; DEXAMETHASONE; LOMUSTINE; MANNITOL; ONDANSETRON; TENIPOSIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COBALT THERAPY; CONFUSION; FEMALE; GASTROINTESTINAL TOXICITY; GLIOBLASTOMA; HEMIPARESIS; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; RADIATION INJURY; THROMBOPHLEBITIS;

ADULT; AGED; BRAIN NEOPLASMS; CAROTID ARTERIES; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; GLIOMA; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 0030898554     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199704000-00006     Document Type: Article

References (35)

1. Rozental JM, Robins I, Finlay J, et al. "Eight-drugs-in-oneday" chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas. Cancer 1989;63: 2475-81.
2. 13N] cisplatin PET to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors. J Nucl Med 1987;28:1844-52.
3. Calvo FA, Pastor MA, Dy C, et al. Intraarterial and intravenous chemotherapy for the treatment of malignant gliomas. Am J Clin Oncol 1985;8:200-9.
4. Calvo FA, Dy C, Henriquez I, et al. Intraarterial and intravenous chemotherapy for the treatment of malignant gliomas: a pilot study. Radiother Oncol 1989;14:83-8.
5. Feun LG, Lee YY, Yung WKA, et al. Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors. Cancer Drug Deliv 1986;3:147-56.
6. Hochberg FH, Pruitt AA, Beck DO, et al. The rationale and methodology for intraarterial chemotherapy with BCNU as treatment for glioblastoma. J Neurosurg 1985;63:1-17.
7. Lehane DE, Bryan RN, Horowitz B, et al. Intraarterial cisplatinum chemotherapy for patients with primary and metastatic brain tumors. Cancer Drug Deliv 1983;1:69-77.
8. Mahaley SM, Hipp SW, Dropcho EJ, et al. Intracarotid cisplatin chemotherapy for recurrent gliomas. J Neurosurg 1989;70:371-8.
9. Stewart DJ, Grahovc Z, Hugenholtz H, et al. Combined intraarterial and systemic chemotherapy for intracerebral tumors. Neurosurgery 1987;21:207-14.
10. Stewart DJ, Leavens M, Maor M, et al. Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 1982;42:2474-9.
11. Alverez MV, Cobreros G, Heras A, et al. Studies of cis-dichlorodiammineplatinum (II) as a radiosensitizer. Br J Cancer 1978;(suppl)37:68-72.
12. Dritschilo A, Piro AJ, Kelman AD. The effect of cis-platinum on the repair of radiation damage in plateau phase Chinese hamster (V-79) cells. Int J Radiat Oncol Biol Phys 1979;5: 1345-9.
13. Murthy AK, Rossof AH, Anderson KM, et al. Cytotoxicity and influence on radiation dose response curve of cis-diamminedichloro-platinum II (cis-DDP). Int J Radiat Oncol Biol Phys 1979;5:1411-5.
14. Burger PC, Vogel FS, Green SB, et al. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985;56:1106-11.
15. MacDonald DR, Cascino TL, Schold SCJ, et al. Response criteria for phase II studies of supratentorial malignant glioma. J Neurosurg 1990;8:1277-80.
16. Kaplan ES, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
17. Greenberg HS, Ensminger WD, Chandler WF, et al. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system. J Neurosurg 1984;61:423-9.
18. Stewart DJ, Wallace S, Feun L, et al. A phase I study of intracarotid artery infusion of cis-diamminedichloroplatinum (II) in patients with recurrent malignant intracerebral tumors. Cancer Res 1982;42:2059-62.
19. Stewart DJ, Grahovac Z, Hugemholtz H, et al. Combined intraarterial and systemic chemotherapy for intracerebral tumors. Neurosurgery 1987;21:207-14.
20. Newton HB, Page MA, Junck L, et al. Intra-arterial cisplatin for the treatment of malignant gliomas. J Neuro-Oncol 1989;7: 39-45.
21. Mahaley SM, Hipp SW, Dropcho EJ, et al. Intracarotid cisplatin chemotherapy for recurrent gliomas. J Neurosurg 1989;70:371-8.
22. Brambilla-Bas BM, Boccardo M. Intracarotid cisplatin chemotherapy for high-grade astrocytomas. J Neurosurg Sci 1993;37: 83-6.
23. Recht L, Fram RJ, Strauss G, et al. Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (CDDP) and i.v. BCNU: a phase II trial. Am J Clin Oncol 1990;13:125-31.
24. Fountzilas G, Karavelis A, Makrantonakis P, et al. Post-operative intracarotid chemotherapy followed by radiation therapy in patients with malignant gliomas. Reg Cancer Treat 1991;3: 332-7.
25. Dropcho EJ, Rosenfeld SS, Morawetz RB, et al. Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. J Clin Oncol 1992;10:452-8.
26. Mortimer JE, Crowley J, Eyre H, et al. A phase II randomized study comparing sequential and combined intraarterial cisplatin and radiation therapy in primary brain tumors. Cancer 1992;69:1220-3.
27. Baram J, Hercbergs A, Lorberboym M, et al. Carboplatin (CP) and hyperfractionated irradiation in malignant brain gliomas [Abstract]. Proc Am Soc Clin Oncol 1992;11:443.
28. Brandes A, Zampierl P, Rigon A, et al. Concurrent radiochemotherapy in high grade gliomas: the Padua experience. [Abstract]. Presented at the Fourth International Congress on Anticancer Chemotherapy, Paris, France, February 1993.
29. Schaake-Koning C, Van den Bogaert W, Dalesio O, et al. Effect of concomitant cisplatin and radiotherapy on inoperable non-small cell cancer. N Engl J Med 1992;326:524-30.
30. Marcial VA, Pajak TF, Mohiuddin M, et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 1990;66:1861-8.
31. Fountzilas G, Skarlos D, Kosmidis P, et al. Radiation therapy and concurrent cisplatin administration in locally advanced head and neck cancer: a Hellenic Co-operative Oncology Group Study. Acta Oncol 1994;33:825-30.
32. EORTC Brain Tumor Group. Cisplatin does not enhance the effect of radiation therapy in malignant gliomas. Eur J Cancer 1991;27:568-71.
33. Byar DP, Green SB, Strike TA. Prognostic factors for malignant gliomas. In: Walker MD, ed. Oncology of the nervous system. Boston: Martinus Nijhoff, 1983:379-81.
34. Janus TJ, Kyritsis AP, Forman AD, Levin VA. Biology and treatment of gliomas. Ann Oncol 1992;3:423-33.
35. Nitta T, Sato K. Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 1995;75:2727-31.